Search

Jessie Lemp, Jami R Kern Global Medical Affairs, Alcon Laboratories, Inc, Fort Worth, Texas, USA Purpose: The objective of the study reported here was to obtain information on acceptance and satisfaction with OPTI-FREE® PureMoist® Multi-Purpose Disinfecting Solution (MPDS) from contact lens wearers globally. Methods: Eligible contact lens wearers provided baseline demographic and lens-wear-regimen information, and advised their ocular dryness/discomfort level and current lens-wear experience. Volunteers received OPTI-FREE PureMoist MPDS and a survey consisting of ten statements about the trial solution. Volunteers were instructed to use the solution daily and to complete the survey after 2 weeks of use. Descriptive statistical analysis was conducted on data from the entire group, from the subset of respondents reporting ocular dryness and/or discomfort at trial initiation (symptomatic subgroup), and from each geographic region. Results: Volunteers from nine countries returned 10,610 surveys, in which 50% of respondents classified themselves as having ocular dryness/discomfort. Lens comfort and visual performance responses from the total population and the symptomatic subgroup were significantly more positive after 2 weeks of OPTI-FREE PureMoist use than at baseline, irrespective of the habitual lens-care solution. In the USA, Southeast Asia, and Europe, 14% to 20% more respondents reported that their contact lenses provided all-day comfort after 2 weeks of OPTI-FREE PureMoist use compared with baseline (P<0.0001). Australia reported 31% more patients with all-day comfort after OPTI-FREE PureMoist use (P<0.0001). Approximately four out of five respondents from both populations reported their intent to continue using OPTI-FREE PureMoist. Globally, 39% of all respondents and 58% of symptomatic respondents experienced reduced end-of-day dryness with their contact lenses after use of OPTI-FREE PureMoist (P<0.0001). Conclusion: Results

Christine W Sindt1, Trudy K Grout1, D Brice Critser1, Jami R Kern2, David L Meadows21University of Iowa Hospitals and Clinics, Iowa City, IA; 2Alcon Research Ltd, Fort Worth, TX, USABackground: The purpose of this study was to assess whether differences in central corneal dendritic immune cell densities associated with combinations of soft contact lenses and lens care solutions could be detected by in vivo confocal microscopy.Methods: Participants were adults naïve to contact lens wear (n = 10) or who wore soft contact lenses habitually on a daily-wear schedule (n = 38) or on a study-assigned schedule for 30 days with daily disposable silicone hydrogel lenses (n = 15). Central corneas were scanned using an in vivo confocal microscope. Cell densities were compared among groups by demographic parameters, lens materials, and lens care solutions (polyhexamethylene biguanide [PHMB], polyquaternium-1 and myristamidopropyl dimethylamine [PQ/MAPD], peroxide, or blister pack solution [for daily disposable lenses]).Results: Among lens wearers, no associations were observed between immune cell densities and age, gender, or years of lens-wearing experience. Mean cell density was significantly lower (P < 0.01) in nonwearers (29 ± 23 cells/mm2, n = 10) than in lens wearers (64 ± 71 cells/mm2, n = 53). Mean cell density was lower (P = 0.21) with traditional polymer lenses (47 ± 44 cells/mm2, n = 12) than with silicone hydrogel lenses (69 ± 77 cells/mm2, n = 41). Lowest to highest mean density of immune cells among lens wearers was as follows: PQ/MAPD solution (49 ± 28 cells/mm2), blister pack solution (63 ± 81 cells/mm2), PHMB solution (66 ± 44 cells/mm2), and peroxide solution (85 ± 112 cells/mm2).Conclusion: In this pilot study, in vivo confocal microscopy was useful for detecting an elevated immune response associated with soft contact lenses, and for identifying lens-related